搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
clinicaltrialsarena
9 小时
Obesity trial surge puts the focus back on decentralisation
As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...
clinicaltrialsarena
12 小时
Pfizer reports positive data from prostate cancer combination therapy trial
Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...
clinicaltrialsarena
11 小时
Rivanna starts trial for AI-enabled Accuro XV imaging system
The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).
clinicaltrialsarena
1 天
Oncoinvent doses first subject in Phase II ovarian cancer treatment trial
The trial will assess Radspherin for the treatment of peritoneal carcinomatosis originating from ovarian cancer. Credit: ...
clinicaltrialsarena
14 小时
Clario partners with PathAI to enhance efficiency in GI clinical trials
Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...
clinicaltrialsarena
1 天
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.
clinicaltrialsarena
1 天
DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial
DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.
clinicaltrialsarena
1 天
Vanqua’s Parkinson’s drug shows promise as company initiates Phase Ib study
Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...
clinicaltrialsarena
1 天
InnoCare’s Phase II psoriasis therapy trial meets primary endpoint
InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...
clinicaltrialsarena
1 天
Priovant mulls broad autoimmune indications for brepacitinib
Priovant expects topline data from two Phase III trials for its dual TYK2 and Jak1 inhibitor in dermatomyositis and uveitis ...
clinicaltrialsarena
2 天
Cassava Sciences: Phase III trials storm ahead amid controversy
Cassava alleged that the short sellers had launched a “short and distort” campaign which caused a “decline in Cassava ...
clinicaltrialsarena
2 天
Allurion’s swallowable balloon hits trial success amid weakening financials
Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈